Skip to main content
. 2014 Aug 13;8:1495–1505. doi: 10.2147/OPTH.S66637

Table 7.

AEs in the per-protocol population

AEs Placebo (N=70) BBOS 1.5% (N=70)
Total AEs 10 24
AEs considered related to test agent 3 8
Ocular AEs
Eye irritation 2 3
Foreign body sensation 1 0
Conjunctival cyst 0 1a
Trace SPK 0 1a

Note:

a

Adverse event considered unrelated to instillation of test agent.

Abbreviations: AE, adverse event; BBOS, bepotastine besilate ophthalmic solution 1.5%; N, number of subjects; SPK, superficial punctate keratitis.